Danaher | DHR - Ativos





Ativos Alterar Data
Abbott USD 108.25B 968M 2026-09
Agilent USD 13.97B 902M 2026-06
Align Technology USD 6.52B 103.03M 2026-09
Becton, Dickinson and Co. USD 50.79B 60M 2026-09
Bio Techne USD 2.64B 50.09M 2026-09
Bio-Rad Laboratories USD 10.78B 531.1M 2026-09
Boston Scientific USD 45.46B 245M 2026-09
Bruker USD 5.83B 224.6M 2026-09
Charles River Laboratories USD 7.45B 80.64M 2026-09
Danaher USD 93.28B 914M 2026-09
Dentsply International USD 5.19B 14M 2026-09
Edwards Lifesciences USD 14.14B 277.3M 2026-09
ESCO Technologies USD 2.42B 14.2M 2026-06
Fortive USD 11.5B 112.2M 2026-09
Henry Schein USD 11.51B 129M 2026-09
Illumina USD 6.81B 162M 2026-09
Intuitive Surgical USD 19.35B 1.53B 2026-09
IQVIA Holdings USD 30.47B 593M 2026-09
Keysight Technologies USD 11.92B 183M 2026-06
Laboratory Of America USD 18.92B 392.3M 2026-09
Medtronic USD 93.31B 278M 2026-06
Mettler Toledo International USD 3.7B 24.53M 2026-09
Myriad Genetics USD 638.9M 34.8M 2026-06
OraSure Technologies USD 360.55M 18.62M 2026-06
Quest Diagnostics USD 17.22B 282M 2026-09
Quidel USD 5.78B 66M 2026-09
Repligen USD 2.93B 23.77M 2026-09
Revvity USD 11.49B 555.49M 2026-09
Roper Industries USD 34.34B 831.2M 2026-09
Stryker USD 47.25B 683M 2026-09
Thermo Fisher Scientific USD 114.23B 1.06B 2026-09
Waters USD 24.12B 636M 2026-09
Zimmer Biomet Holdings USD 23.54B 740.8M 2026-09